V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
B
BMRNAI Stock Diagnostic Report

BioMarin presents five-year data on Pompe disease treatment

BioMarin has announced 5-year clinical data for its Fabry disease treatment, but the impact on the stock price is assessed as neutral as the direction of the data is not clear.

View Source Article ↗
AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

BMRN Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-02 15:25:39BMRN50MidView Report →
2026-08-19 19:25:58BMRN75MidView Report →
2026-08-18 13:11:59BMRN85S-ClassView Report →
View Full History for BMRN (Blueprint) →